Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients

Journal of Thrombosis and Thrombolysis

Volumn 35, Issue 1, 2013, Pages 100-106

  Attaya, Hosam ^a   Wysokinski, Waldemar E ^a   Bower, Thomas ^a   Litin, Scott ^a   Daniels, Paul R ^a   Slusser, Joshua ^a   Heit, John A ^a   Mcbane, Robert D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bridging therapy; Heparin; Low molecular weight heparin; Surgery; Vascular bypass graft; Warfarin

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTERY BYPASS; ARTICLE; AUTOGRAFT; BLEEDING; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; DRUG INDICATION; FEMALE; GRAFT OCCLUSION; GRAFT PATENCY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART VALVE PROSTHESIS; HUMAN; INCIDENCE; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 84871803716     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0787-6     Document Type: Article

References (27)

1. Dutch Bypass Oral anticoagulants or Aspirin (BOA) Study Group (2000) Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (the Dutch bypass oral anticoagulants or aspirin study): a randomized trial. Lancet 355:346-351
2. Sarac TP, Huber TS, Back MR et al (1998) Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. J Vasc Surg 28:446-457
3. Sobel M, Verhaeghe R (2008) Antithrombotic therapy for peripheral artery occlusive disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 133:815S-843S
4. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G (2008) Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 133:160S-198S
5. Douketis JD, Berger PB, Dunn AS (2008) The perioperative management of antithrombotic therapy: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 133:299S-339S
6. Daniels PR, McBane RD, Litin SC et al (2009) Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Thromb Res 124:300-305
7. Kovacs MJ, Kearon C, Rodger M et al (2004) Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 110:1658-1663
8. Wysokinski WE, McBane RD, Daniels PR et al (2008) periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc 83:639-645
9. Spyropoulos AC, Turpie AG, Dunn AS et al (2006) Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost 4:1246-1252
10. McBane RD, Wysokinski WE, Daniels PR et al (2010) Periprocedural anticoagulation management of patients with venous thromboembolism. Arterioscler Thromb Vasc Biol 30:442-448
11. Dunn AS, Spyropoulos AC, Turpie AG (2007) Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 5:2211-2218
12. Douketis JD, Foster GA, Crowther MA et al (2000) Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 160:3431-3436
13. Thatipelli MR, Pellikka PA, McBane RD et al (2007) Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease. J Vasc Surg 46:62-70
14. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE (1984) International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 108:150-158
15. Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692-694
16. Pomposelli FB, LoGerfo FW (2005) The autogenous vein. In: Rutherford RB, Cronenwett JL, Gloviczki P, Johnston KW, Krupski WC, Ouriel K, Sidawy AN (eds) Rutherford Vascular Surgery, 6th edn. Elsevier Saunders, Philadelphia, pp 695-715
17. Xu L, Greisler HP (2005) Prosthetic grafts. In: Rutherford RB, Cronenwett JL, Gloviczki P, Johnston KW, Krupski WC, Ouriel K, Sidawy AN (eds) Rutherford Vascular Surgery, 6th edn. Elsevier Saunders, Philadelphia, pp 723-740
18. Wengerter KR, Veith FJ, Gupta SK et al (1991) Prospective randomized multicenter comparison of in situ and reversed vein infrapopliteal bypasses. J Vasc Surg 13:189-197
19. Watelet J, Soury P, Menard JF et al (1997) Femoropopliteal bypass: in situ or reversed vein grafts? ten-year results of a randomized prospective study. Ann Vasc Surg 11(5):510-519
20. Moody AP, Edwards PR, Harris PL (1992) In situ versus reversed femoropopliteal vein grafts: long-term follow-up of a prospective, randomized trial. Br J Surg 79:750-752
21. Veith FJ, Gupta SK, Ascer E et al (1986) Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3:104-114
22. Klinkert P, Schepers A, Burger DH, van Bockel JH, Breslau PJ (2003) Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg 37:149-155
23. Johnson WC, Lee KK (2000) A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs Cooperative Study. J Vasc Surg 32:268-277
24. Hirsch AT, Haskal ZJ, Hertzer NR et al (2006) American Association for Vascular Surgery, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease, American Association of Cardiovascular and Pulmonary Rehabilitation, National Heart, Lung, and Blood Institute, Society for Vascular Nursing, TransAtlantic Inter-Society Consensus, Vascular Disease Foundation. Circulation 113:e463-e654
25. de Vries SO, Hunink MG (1997) Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg 26:558-569
26. McBane RD 2nd, Karnicki K, Miller RS, Owen WG (2004) The impact of peripheral arterial disease on circulating platelets. Thromb Res 113:137-145
27. Madsen EH, Gehr NR, Johannesen NL, Schmidt EB, Kristensen SR (2011) Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis. Platelets 22(7):537-546 (Epub 2011 May 19)